FDA ANDA · ANDA220722
LOPERAMIDE HYDROCHLORIDE
Sponsor: TARO
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
ANDA220722
TYPE
ANDA
ORIGINAL APPROVAL
2026-09-30
LATEST ACTION
2026-09-30
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Over-the-counter
Products
LOPERAMIDE HYDROCHLORIDEOver-the-counter
LOPERAMIDE HYDROCHLORIDE 2MG · CAPSULE · ORAL
Approval history
2026-09-30UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →